xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72588 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGPEAW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357433 | 1 | Figure 1 | Positive-High | true | 250.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72590 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGPEYA | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357434 | 1 | Figure 1 | Positive-High | true | 860.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72671 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WKEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357435 | 1 | Figure 1 | Positive-Low | true | 7980.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72633 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIKQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357436 | 1 | Figure 1 | Positive-High | true | 820.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72576 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEKEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357437 | 1 | Figure 1 | Positive-Intermediate | true | 1270.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72598 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQKGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357438 | 1 | Figure 1 | Positive-Low | true | 61700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72597 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEKPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357439 | 1 | Figure 1 | Positive-High | true | 460.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72586 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGKEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357440 | 1 | Figure 1 | Positive-Low | true | 145000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72594 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGPKYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357441 | 1 | Figure 1 | Positive-Low | true | 8710.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72589 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGPEKW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357442 | 1 | Figure 1 | Positive-High | true | 710.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72591 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGPEYK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357443 | 1 | Figure 1 | Positive-Low | true | 11200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 73242 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WWEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357444 | 1 | Figure 2 | Positive-High | true | 130.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WFEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357445 | 1 | Figure 2 | Positive-High | true | 220.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72981 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WQEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357446 | 1 | Figure 2 | Positive-Intermediate | true | 3770.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72297 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WDEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357447 | 1 | Figure 2 | Positive-Low | true | 8190.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72346 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WEEQEGPEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357448 | 1 | Figure 2 | Positive-Intermediate | true | 1290.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72596 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGWEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357449 | 1 | Figure 2 | Positive-Low | true | 23900.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72585 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGIEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357450 | 1 | Figure 2 | Positive-Intermediate | true | 1400.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72595 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGQEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357451 | 1 | Figure 2 | Positive-Intermediate | true | 4450.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 72583 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WIEQEGDEYW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357452 | 1 | Figure 2 | Positive-High | true | 180.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315167.xml | 315167 | 2025-11-06-08:00 | 8921967 | 1,996 | The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. | European journal of immunology | F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid | 1835 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AIAAEAPEAW | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1357454 | 1 | Figure 2 | Positive-High | true | 90.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315169.xml | 315169 | 2025-11-06-08:00 | 8946687 | 1,996 | Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E. | Tissue antigens | C M Tzeng; E J Adams; J E Gumperz; L Percival; R S Wells; P Parham; L D Barber | 229910 | LAVHPSGVAL | FragmentOfANaturalSequenceMolecule | Peptide from protein | LAVHPSGVAL | 10 | null | 45 | 54 | 9606 | P05161.5 | null | Exact Epitope | Representative selection | MhcLigandElution | 2117480 | 252 | Table 1 | Positive | true | null | null | null | null | null | 308 | null | null | null | null | null | null | null | 5 |
315169.xml | 315169 | 2025-11-06-08:00 | 8946687 | 1,996 | Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E. | Tissue antigens | C M Tzeng; E J Adams; J E Gumperz; L Percival; R S Wells; P Parham; L D Barber | 229895 | FAYDGKDYLTL | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAYDGKDYLTL | 11 | null | 25 | 35 | 9606 | CAA05527.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2117481 | 252 | Table 1 | Positive | true | null | null | null | null | null | 308 | null | null | null | null | null | null | null | 7 |
315169.xml | 315169 | 2025-11-06-08:00 | 8946687 | 1,996 | Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E. | Tissue antigens | C M Tzeng; E J Adams; J E Gumperz; L Percival; R S Wells; P Parham; L D Barber | 229895 | FAYDGKDYLTL | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAYDGKDYLTL | 11 | null | 25 | 35 | 9606 | CAA05527.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117482 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315169.xml | 315169 | 2025-11-06-08:00 | 8946687 | 1,996 | Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E. | Tissue antigens | C M Tzeng; E J Adams; J E Gumperz; L Percival; R S Wells; P Parham; L D Barber | 78970 | FAYDGKDYL | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAYDGKDYL | 9 | null | 25 | 33 | 9606 | CAA05527.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117484 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 51685 | EBNA-6B 213-222 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QNGALAINTF | 10 | null | 213 | 222 | 10376 | Q69140.1 | null | Exact Epitope | Not determined | TCell | 1378477 | 67 | Figures 2, 3, and 4, table 2 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 299 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 6 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 51685 | EBNA-6B 213-222 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QNGALAINTF | 10 | null | 213 | 222 | 10376 | Q69140.1 | null | Exact Epitope | Not determined | TCell | 1378478 | 67 | Figure 1 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 299 | null | T cell CD8+ | blood | Cell Line / Clone | Not determined | Not determined | null | 6 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 51685 | EBNA-6B 213-222 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QNGALAINTF | 10 | null | 213 | 222 | 10376 | Q69140.1 | null | Exact Epitope | Not determined | TCell | 1378480 | 67 | Figures 1, 3, and 4, table 1 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 299 | null | T cell CD8+ | blood | Cell Line / Clone | Not determined | Not determined | null | 6 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 37153 | EBNA-6A/6B 284-293 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLDFVRFMGV | 10 | null | 284 | 293 | 10376 | P03204.1 | null | Exact Epitope | Not determined | TCell | 1378481 | 67 | Figure 1 and table 1 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Not determined | Not determined | null | 8 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 37153 | EBNA-6A/6B 284-293 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLDFVRFMGV | 10 | null | 284 | 293 | 10376 | P03204.1 | null | Exact Epitope | Not determined | TCell | 1378482 | 67 | Table 2 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 299 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 8 |
315171.xml | 315171 | 2026-01-07-08:00 | 8971014 | 1,996 | Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. | Journal of virology | B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley | 37153 | EBNA-6A/6B 284-293 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLDFVRFMGV | 10 | null | 284 | 293 | 10376 | P03204.1 | null | Exact Epitope | Not determined | TCell | 1378483 | 67 | Figure 1 | Positive | true | null | 9606 | null | 17 years | DOID:934 | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Not determined | Not determined | null | 8 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137628 | DR1/22-35 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ERVRLLERCIYNQE | 14 | null | 22 | 35 | 9606 | CAA68171.1 | null | Exact Epitope | Representative selection | TCell | 1795806 | 69 | Table I, Figures 1, 2, 3, and 5 | Positive | true | null | 9606 | M | null | null | 419 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137628 | DR1/22-35 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ERVRLLERCIYNQE | 14 | null | 22 | 35 | 9606 | CAA68171.1 | null | Exact Epitope | Representative selection | TCell | 1795809 | 73 | Figures 3 and 4 | Positive | true | null | 9606 | M | null | null | 419 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137628 | DR1/22-35 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ERVRLLERCIYNQE | 14 | null | 22 | 35 | 9606 | CAA68171.1 | null | Exact Epitope | Representative selection | MhcBinding | 1795790 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137621 | DR1/22-35 24V/E | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERERLLERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795791 | 295 | Table I | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137636 | DR1/22-35 24V/Y | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERYRLLERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795792 | 295 | Table I | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137622 | DR1/22-35 25R/A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVALLERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795793 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137624 | DR1/22-35 26L/I | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRILERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795795 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137634 | DR1/22-35 26L/V | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRVLERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795797 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137633 | DR1/22-35 26L/T | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRTLERCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795798 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137632 | DR1/22-35 27L/V | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLVERCIYNQ | 13 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795799 | 295 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137630 | DR1/22-35 28E/Q | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLQRCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795800 | 295 | Table I | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137625 | DR1/22-35 28E/D | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLDRCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795801 | 295 | Table I | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137629 | DR1/22-35 28E/N | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLNRCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795802 | 295 | Table I | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137631 | DR1/22-35 28E/S | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLSRCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795803 | 295 | Table I | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137626 | DR1/22-35 29R/A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLEACIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795804 | 295 | Table I | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315173.xml | 315173 | 2025-11-06-08:00 | 8977174 | 1,997 | Allopeptide-specific T cell reactivity altered by peptide analogs. | Journal of immunology (Baltimore, Md. : 1950) | A I Colovai; Z Liu; P E Harris; R Cortesini; N Suciu-Foca | 137627 | DR1/22-35 29R/K | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ERVRLLEKCIYNQE | 14 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1795805 | 295 | Table I | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 138773 | ribL36 (36–44) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRLTKHTKF | 9 | null | 31 | 39 | 10116 | NP_071949.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423497 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 190 | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 138773 | ribL36 (36–44) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRLTKHTKF | 9 | null | 31 | 39 | 10116 | NP_071949.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423509 | 185 | Figure 3 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 138773 | ribL36 (36–44) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRLTKHTKF | 9 | null | 31 | 39 | 10116 | NP_071949.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423510 | 185 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 132051 | R-11-L | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | AJG01750.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423498 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 190 | null | null | null | null | null | null | null | 8 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 132051 | R-11-L | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | AJG01750.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423511 | 185 | Figures 3 and 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 132051 | R-11-L | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | AJG01750.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423512 | 185 | Figures 3 and 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236185 | S21 (44-53) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRFNGQFKTY | 10 | null | 44 | 53 | 9606 | NP_001015.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423499 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 190 | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 55556 | C5 (127–135) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRFFPYYVY | 9 | null | 127 | 135 | 9606 | SNHUC5 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423500 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 190 | null | null | null | null | null | null | null | 6 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 55556 | C5 (127–135) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRFFPYYVY | 9 | null | 127 | 135 | 9606 | SNHUC5 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423501 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 6 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 55785 | H3.3 (52–60) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYQKSTEL | 9 | null | 53 | 61 | 9606 | NP_002098.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423502 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236214 | S25 (103-111) | FragmentOfANaturalSequenceMolecule | Peptide from protein | HRAQVIYTR | 9 | null | 103 | 111 | 9606 | AAH04294.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423503 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 5 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236304 | peptide 1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRISGVDRYY | 10 | null | 52 | 61 | 9606 | O15239.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2423504 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236237 | eIF-2 (445–453) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KRFEHWRL | 8 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcLigandElution | 2423505 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 9 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372101 | protC5 (127–135) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRFMPYYVY | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcLigandElution | 2423506 | 91 | Figure 1 and Table I | Positive | true | null | null | null | null | null | 188 | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372101 | protC5 (127–135) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRFMPYYVY | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcBinding | 2423513 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372101 | protC5 (127–135) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRFMPYYVY | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcBinding | 2423514 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 302918 | gp 120 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRAFVTIGK | 9 | null | 314 | 322 | 11676 | ACB38955.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423515 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 302918 | gp 120 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRAFVTIGK | 9 | null | 314 | 322 | 11676 | ACB38955.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423516 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 60867 | NP | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 11320 | AAA43467.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423517 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 60867 | NP | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 11320 | AAA43467.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423518 | 185 | Figure 3 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 55785 | H3.3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYQKSTEL | 9 | null | 19 | 27 | 9606 | CAA29288.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423519 | 185 | Figures 3 and 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 55785 | H3.3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYQKSTEL | 9 | null | 19 | 27 | 9606 | CAA29288.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423520 | 185 | Figures 3 and 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236214 | ribS25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | HRAQVIYTR | 9 | null | 103 | 111 | 9606 | AAH04294.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423523 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 236214 | ribS25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | HRAQVIYTR | 9 | null | 103 | 111 | 9606 | AAH04294.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423524 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 39203 | L-9-K | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 167 | 175 | 9606 | ACD01076.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423525 | 185 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 39203 | L-9-K | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 167 | 175 | 9606 | ACD01076.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423526 | 185 | Figure 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372763 | R-8-K | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGK | 8 | null | 168 | 175 | 9606 | ACD01076.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423527 | 185 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372763 | R-8-K | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGK | 8 | null | 168 | 175 | 9606 | ACD01076.1 | null | Exact Epitope | Representative selection | MhcBinding | 2423528 | 185 | Figure 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372764 | R-9-L | SequenceMoleculeNoNaturalSource | Peptide, no natural source | RRYLGKETL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 2423529 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 372764 | R-9-L | SequenceMoleculeNoNaturalSource | Peptide, no natural source | RRYLGKETL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 2423530 | 185 | Figure 3 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 124348 | HLA-A29 endogenous ligand | FragmentOfANaturalSequenceMolecule | Peptide from protein | KEFQEHYEY | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcBinding | 2423694 | 185 | Figures 3 and 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315174.xml | 315174 | 2026-03-17-07:00 | 8981922 | 1,996 | Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. | The Journal of clinical investigation | F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert | 124348 | HLA-A29 endogenous ligand | FragmentOfANaturalSequenceMolecule | Peptide from protein | KEFQEHYEY | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcBinding | 2423695 | 185 | Figures 3 and 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2117504 | 252 | Figure 1, Table 1 | Positive | true | null | null | null | null | null | 186 | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2117505 | 252 | Figure 1, Table 1 | Positive | true | null | null | null | null | null | 189 | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2117506 | 252 | Figure 1, Table 1 | Positive | true | null | null | null | null | null | 191 | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117508 | 297 | Figure 2 | Positive-Low | true | 20000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117509 | 297 | Figure 2 | Positive-High | true | 700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117510 | 297 | Figure 2 | Positive-Intermediate | true | 8000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 132051 | HLA-B27 169-179 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRYLENGKETL | 11 | null | 193 | 203 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117511 | 297 | Figure 2 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 39203 | HLA-B27 168-176 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 192 | 200 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117515 | 297 | Figure 2 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 39203 | HLA-B27 168-176 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 192 | 200 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117516 | 297 | Figure 2 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 39203 | HLA-B27 168-176 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 192 | 200 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117517 | 297 | Figure 2 | Positive-Low | true | 30000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 39203 | HLA-B27 168-176 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LRRYLENGK | 9 | null | 192 | 200 | 9606 | CAA27578.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117518 | 297 | Figure 2 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 55734 | EBV-LMP2 (RRRWRRLTV) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRWRRLTV | 9 | null | 235 | 243 | 10376 | P0C729.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117519 | 297 | Figure 2 | Positive-High | true | 800.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 55734 | EBV-LMP2 (RRRWRRLTV) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRWRRLTV | 9 | null | 235 | 243 | 10376 | P0C729.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117520 | 297 | Figure 2 | Positive-High | true | 200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 55734 | EBV-LMP2 (RRRWRRLTV) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRWRRLTV | 9 | null | 235 | 243 | 10376 | P0C729.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117521 | 297 | Figure 2 | Positive-High | true | 700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315179.xml | 315179 | 2026-02-11-08:00 | 9027961 | 1,997 | HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. | Tissue antigens | F García; A Marina; J P Albar; J A López de Castro | 55734 | EBV-LMP2 (RRRWRRLTV) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRWRRLTV | 9 | null | 235 | 243 | 10376 | P0C729.1 | null | Exact Epitope | Representative selection | MhcBinding | 2117522 | 297 | Figure 2 | Positive-Intermediate | true | 3000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 28247 | M. leprae Hsp70 p413-422 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IQVYQGEREI | 10 | null | 413 | 422 | 1769 | AAA25362.1 | null | Exact Epitope | Not determined | TCell | 1353550 | 84 | Table 1 | Positive | true | null | 9606 | null | null | null | 333 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 28247 | M. leprae Hsp70 p413-422 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IQVYQGEREI | 10 | null | 413 | 422 | 1769 | AAA25362.1 | null | Exact Epitope | Not determined | TCell | 1353548 | 73 | Table 1 | Positive | true | null | 9606 | null | null | null | 333 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 28247 | M. leprae Hsp70 p413-422 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IQVYQGEREI | 10 | null | 413 | 422 | 1769 | AAA25362.1 | null | Exact Epitope | Not determined | TCell | 1353546 | 67 | Table 1 | Positive | true | null | 9606 | null | null | null | 333 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 28247 | M. leprae Hsp70 p413-422 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IQVYQGEREI | 10 | null | 413 | 422 | 1769 | AAA25362.1 | null | Exact Epitope | Not determined | TCell | 1353687 | 69 | Figures 3 and 5 | Positive | true | null | 9606 | null | null | null | 333 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 13596 | M. leprae Hsp70 p471-486 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENTIKIQEGSGLSKEE | 16 | null | 471 | 486 | 1769 | AAA25362.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1353561 | 84 | Table 1 | Positive | true | null | 9606 | null | null | null | 327 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
315183.xml | 315183 | 2011-10-28-07:00 | 9038316 | 1,997 | Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. | Infection and immunity | E Adams; A Basten; S Rodda; W J Britton | 13596 | M. leprae Hsp70 p471-486 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENTIKIQEGSGLSKEE | 16 | null | 471 | 486 | 1769 | AAA25362.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1353613 | 78 | Table 1 | Positive | true | null | 9606 | null | null | null | 327 | null | T cell | Blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.